These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21477010)

  • 1. Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course.
    Warren RB; Kleyn CE; Gulliver WP
    Br J Dermatol; 2011 May; 164 Suppl 1():1-14. PubMed ID: 21477010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis: is the impairment to a patient's life cumulative?
    Kimball AB; Gieler U; Linder D; Sampogna F; Warren RB; Augustin M
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):989-1004. PubMed ID: 20477920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative life course impairment: evidence for psoriasis.
    Mattei PL; Corey KC; Kimball AB
    Curr Probl Dermatol; 2013; 44():82-90. PubMed ID: 23796812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative life course impairment: the imprint of psoriasis on the patient's life.
    Ros S; Puig L; Carrascosa JM
    Actas Dermosifiliogr; 2014 Mar; 105(2):128-34. PubMed ID: 23668623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative life course impairment: identifying patients at risk.
    Augustin M
    Curr Probl Dermatol; 2013; 44():74-81. PubMed ID: 23796811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative life course impairment in patients with dermatological diseases, with a focus on psoriasis.
    Romiti R; Magalhães RF; Duarte GV
    An Bras Dermatol; 2024; 99(2):269-276. PubMed ID: 38135557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early intervention and cumulative life course impairment in psoriasis: a review.
    Arancio LMH; D'Amico D; Dastoli S; Fiorella CS; Manfredini M; Moretta G; Paolino G; Levi A; Di Fino S; Zucchi B; Piaserico S
    Clin Exp Dermatol; 2024 Nov; 49(12):1525-1531. PubMed ID: 39045914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' narratives.
    Foulkes AC; Warren RB
    Curr Probl Dermatol; 2013; 44():145-57. PubMed ID: 23796819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life course impairment and quality of life over time.
    Sampogna F
    Curr Probl Dermatol; 2013; 44():47-51. PubMed ID: 23796808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis - The Life Course Approach.
    Linder MD; Piaserico S; Augustin M; Fortina AB; Cohen AD; Gieler U; Jemec GB; Kimball AB; Peserico A; Sampogna F; Warren RB; de Korte J
    Acta Derm Venereol; 2016 Aug; 96(217):102-8. PubMed ID: 27283774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concept of major life-changing decisions in life course research.
    Bhatti ZU; Salek S; Finlay AY
    Curr Probl Dermatol; 2013; 44():52-66. PubMed ID: 23796809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative life course impairment in melanoma and nonmelanoma skin cancer.
    Piaserico S
    Curr Probl Dermatol; 2013; 44():118-24. PubMed ID: 23796815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Setting up a life course questionnaire.
    Sampogna F
    Curr Probl Dermatol; 2013; 44():67-73. PubMed ID: 23796810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vitiligo on self-reported health-related quality of life.
    Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
    Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative life course impairment in vitiligo.
    Krüger C; Schallreuter KU
    Curr Probl Dermatol; 2013; 44():102-17. PubMed ID: 23796814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major life changing decisions and cumulative life course impairment.
    Bhatti ZU; Salek MS; Finlay AY
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):245-6; author reply 246. PubMed ID: 21118311
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical characteristics associated with illness perception in psoriasis.
    Wahl AK; Robinson HS; Langeland E; Larsen MH; Krogstad AL; Moum T
    Acta Derm Venereol; 2014 May; 94(3):271-5. PubMed ID: 24002676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two key concepts in the life course approach in medicine: allostatic load and cumulative life course impairment.
    Offidani E; Tomba E; Linder MD
    Curr Probl Dermatol; 2013; 44():17-32. PubMed ID: 23796806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychosocial burden of psoriasis.
    Kimball AB; Jacobson C; Weiss S; Vreeland MG; Wu Y
    Am J Clin Dermatol; 2005; 6(6):383-92. PubMed ID: 16343026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis uncovered--measuring burden of disease impact in a survey of Australians with psoriasis.
    Baker CS; Foley PA; Braue A
    Australas J Dermatol; 2013 Feb; 54 Suppl 1():1-6. PubMed ID: 23379483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.